Therapeutic effect of inhaled budesonide in transient tachypnea of newborn: A placebo-controlled study

Phase 1

Completed

• Conditions: Transient Tachypnea of newborn; tachypnea , neonate

• Registration Number: TCTR20200513005
• Lead Sponsor: mohamed shawky elfarargy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-07-01
• Study Start: 2020-05-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

full term neonates

Exclusion Criteria

preterm neonates

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Transient Tachypnea of the newborn at 3 days after end of the intervention( inhaled budesonide) pulse oximeter to measure peripheral oxygen saturation

Secondary Outcome Measures

Name	Time	Method
none none none